BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 4, 2008
View Archived Issues
Adherex presents phase I/II results on ADH-1, a novel N-cadherin-targeting oncolytic
Read More
New treatment options for cancer reported in recent patent literature
Read More
Gradalis reports on novel autologous tumor cell vaccine for advanced cancer
Read More
Hana's phase II Marqibo trial meets clinical response criteria
Read More
Synosia commences phase IIa trial for potential first-in-class treatment for PD
Read More
FDA grants approval to Ark Therapeutics' SPA and IND for phase III trial of Trinam in ESRD
Read More
Locus enters research collaborations for p38 inhibitors
Read More
Daiichi Sankyo launches Gracevit tablets in Japan
Read More
ProStrakan presents an update on FDA's review of NDA for Sancuso in CINV
Read More
Bavarian Nordic enters clinical trials with prostate cancer vaccine
Read More
MDX-1100 safe and well tolerated in phase I study
Read More
Immune and clinical responses seen with CTL vaccine IDM-2101 in non-small cell lung cancer
Read More
Phase I study shows safety of E-7820 and cetuximab combination in solid tumor patients
Read More
Inflammation and joint destruction inhibited in arthritis mouse model by ABD-345
Read More
CHMP issues positive opinion for Sugammadex in reversal of muscle relaxants
Read More
Rexahn commences phase II trial for Zoraxel to treat erectile dysfunction
Read More
Calando doses first patient in siRNA phase I clinical trial
Read More
Acorda announces positive phase III Fampridine-SR data in patients with MS
Read More
Altus reports top-line results from ALTU-237 phase I clinical trial
Read More
Recent Kowa patent describes new agents for respiratory disorders
Read More
Novel therapeutic agents for osteoporosis disclosed in recent Wyeth patents
Read More
Auxilium's Xiaflex meets primary endpoint in pivotal phase III study
Read More
PsychoGenics announces positive phase IIa data for eltoprazine in ADHD
Read More
AstraZeneca submits sNDA for Symbicort for treating asthma in children as young as age six
Read More
Sunesis focuses resources on voreloxin development
Read More